Smallpox and Other Viral Agents

Smallpox and Other Viral Agents

Smallpox and Other Viral Agents

On this page

Smallpox (Variola Virus) - Pox On You!

  • Agent: Variola virus (dsDNA, Poxviridae). Globally eradicated (1980).
  • Transmission: Respiratory droplets, direct contact (lesions/fomites). Highly contagious.
  • Incubation: 7-17 days.
  • Clinical:
    • Prodrome: High fever, malaise, severe headache/backache.
    • Rash: Macules → papules → vesicles → pustules → scabs.
    • Distribution: Centrifugal (face, extremities > trunk). 📌 "SmallPOX, lesions on the periphery BOX".
    • Lesions: Deep-seated, firm, umbilicated.
  • Mortality: Variola major ~30%; V. minor <1%.
  • Diagnosis: EM (Guarnieri bodies - intracytoplasmic eosinophilic inclusions), PCR.
  • Prevention/Tx: Vaccination (Vaccinia virus); Tecovirimat, Cidofovir.
  • BT: Category A agent. Smallpox vs Chickenpox Rash Comparison

⭐ Smallpox rash is centrifugal, lesions are all in the same stage of development in an affected area.

Viral Hemorrhagic Fevers (VHFs) - Code Red Bleeders

Clinical presentations of Viral Hemorrhagic Fevers

  • Key Agents: Filoviruses (Ebola, Marburg), Arenaviruses (Lassa), Bunyaviruses (CCHF, Hantavirus), Flaviviruses (Dengue, Yellow Fever).
  • Pathogenesis: RNA viruses. Cause endothelial damage → ↑vascular permeability, coagulopathy, shock.
  • Clinical: Abrupt onset: fever, myalgia, headache. Progresses to GI symptoms, rash, bleeding (petechiae to severe hemorrhage), organ failure.
  • Transmission:
    • Zoonotic reservoirs (rodents, bats, ticks, mosquitoes).
    • Human-to-human via body fluids (high risk in healthcare).
  • Diagnosis: RT-PCR (early), serology (later).
  • Management: Supportive care (fluids, electrolytes, vasopressors). Strict barrier nursing.

    ⭐ Ribavirin is useful for Lassa Fever and CCHF.

Other Viral Bioterror Agents - Stealthy Spreaders

  • Highly Pathogenic Avian Influenza (HPAI): e.g., H5N1, H7N9.
    • Potential for aerosol spread, high mortality.
    • Risk of genetic reassortment → pandemic strains.
  • Arboviruses: e.g., Chikungunya, Rift Valley Fever, Japanese Encephalitis.
    • Vector-borne (mosquitoes, ticks); potential for large outbreaks.
    • Stealthy: difficult early detection, rapid spread.
  • Nipah Virus: Zoonotic (bats, pigs); respiratory & neurological disease; high fatality.

⭐ Highly Pathogenic Avian Influenza (HPAI) H5N1 is a concern due to potential for aerosol spread and high mortality.

Lab Diagnosis & Antivirals - Viral Counterstrikes

  • Lab Diagnosis (Smallpox):
    • PCR (vesicular fluid, scabs): Rapid, specific; gold standard.
    • Electron Microscopy (EM): Brick-shaped virions, Guarnieri bodies (intracytoplasmic).
    • Viral culture (BSL-4); Serology (retrospective).
  • Lab Diagnosis (Other VHFs e.g., Ebola, Lassa):
    • RT-PCR (RNA viruses); ELISA (antigen/antibody).
  • Antivirals (Smallpox):
    • Tecovirimat (TPOXX/ST-246): Viral p37 envelope protein inhibitor.

      ⭐ Tecovirimat (TPOXX) is an important antiviral for smallpox.

    • Cidofovir: DNA polymerase inhibitor; nephrotoxic.
    • Brincidofovir: Oral cidofovir prodrug, less nephrotoxic.
  • Antivirals (Other VHFs):
    • Ribavirin: For Lassa, CCHF, Hantavirus.
    • Supportive care is primary.

Prevention & Prophylaxis - Viral Shield Up!

  • Core Measures: Rapid isolation, contact tracing, strict PPE (N95/PAPR, gowns, gloves, eye protection), environmental decontamination.
  • Smallpox:
    • Vaccination: Live Vaccinia Virus (VV). 📌 "Vax to Vanquish Variola!"

      ⭐ Smallpox vaccination uses live vaccinia virus and can be effective even post-exposure (within 3-4 days).

    • PEP: Vaccine within 3-4 days post-exposure. Ring vaccination strategy.
    • Antivirals: Tecovirimat.
  • Viral Hemorrhagic Fevers (VHFs):
    • Ebola: rVSV-ZEBOV vaccine (pre/post-exposure). mAbs (Inmazeb, Ebanga).
    • Lassa: Ribavirin PEP (early).
    • Strict barrier nursing, safe burials, vector control.

High‑Yield Points - ⚡ Biggest Takeaways

  • Smallpox (Variola): DNA virus, aerosol transmission; centrifugal rash (lesions same stage); Guarnieri bodies.
  • Smallpox post-exposure: Vaccinia vaccine within 4 days.
  • Viral Hemorrhagic Fevers (VHFs) (e.g., Ebola): RNA viruses causing severe systemic illness.
  • VHFs cause increased vascular permeability, leading to hemorrhage and shock; mainstay of treatment is supportive care.
  • Ribavirin is effective against Lassa fever, CCHF, and Hantavirus.
  • Strict barrier nursing and infection control are crucial for VHF management.

Practice Questions: Smallpox and Other Viral Agents

Test your understanding with these related questions

Post-exposure prophylaxis is indicated in?

1 of 5

Flashcards: Smallpox and Other Viral Agents

1/3

_____ is an exotoxin from Bacillus anthracis that mimics Adenylate Cyclase, thereby increasing cAMP levels.

TAP TO REVEAL ANSWER

_____ is an exotoxin from Bacillus anthracis that mimics Adenylate Cyclase, thereby increasing cAMP levels.

Edema Factor

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial